CHINAAMC Hang Seng Biotech ETF (HKG:3069)
Hong Kong · Delayed Price · Currency is HKD 15.97
-0.05 (-0.31%)
Last updated: Jul 25, 2025
HKG:3069 Holdings Information
HKG:3069 is an equity ETF with a total of 10 individual holdings. The top holdings are Innovent Biologics stock at 11.01%, WuXi Biologics at 9.43%, BeOne Medicines at 8.93%, CSPC Pharmaceutical Group at 6.19%, and Akeso at 6.15%.
Total Holdings
10
Top 10 Percentage
60.85%
Asset Class
Equity
ETF Category
Health Care
Assets
919.19M
PE Ratio
21.24
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | HKG: 1801 | Innovent Biologics, Inc. | 11.01% |
| 2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 9.43% |
| 3 | HKG: 6160 | BeOne Medicines Ltd. | 8.93% |
| 4 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 6.19% |
| 5 | HKG: 9926 | Akeso, Inc. | 6.15% |
| 6 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.40% |
| 7 | HKG: 1530 | 3SBio Inc. | 4.51% |
| 8 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.51% |
| 9 | HKG: 9688 | Zai Lab Limited | 2.99% |
| 10 | HKG: 2359 | WuXi AppTec Co., Ltd. | 2.73% |
As of Jun 30, 2025